Clinical Oncology Specialist - Lymphoma; OH, IN, KY, MI

We are looking for a Clinical Oncology Specialist – Lymphoma to join our team in a field-based oncology diagnostics sales role. This is an exciting opportunity to drive the adoption and sales growth of Signatera, the first-to-market MRD CtDNA test, with a primary focus on Lymphoma within a defined territory. In this role, you will make a meaningful impact in oncology diagnostics, advancing patient care through innovative technology while collaborating with leading healthcare professionals.

LOCATION: This role’s designated territory covers the Eastern Midwest, including key cities in Ohio—Cincinnati, Columbus, and Cleveland—along with major markets in Michigan, Indiana, and Kentucky.

• Develop expertise in Natera’s products, services, processes, policies, and teams, as well as competitor offerings, market practices, and payer/reimbursement dynamics to effectively position Signatera.
• Achieve sales targets by driving new patient adoption, expanding the user base, and acquiring accounts.
• Develop and execute a comprehensive business plan to gain and retain clients, aligning with national goals and organizational values.
• Execute sales strategies and tactics, implementing sales and marketing plans to maximize pull-through opportunities.
• Target academic Hematologists, Medical Oncologists, Pathologists, and select community oncology sites to drive adoption.
• Execute a strategic territory plan, managing sales performance, new account acquisition, customer retention, and revenue growth.
• Build and maintain trusted relationships with physicians and accounts through education, strategic initiatives, and innovative solutions.
• Partner with solid tumor-focused COS, ACOS, and Medical Affairs to drive renewals, resolve missing information issues, and optimize revenue.
• Work with Key Opinion Leaders (KOLs) and key stakeholders to develop care pathways, institutional partnerships, and EMR integrations at academic and community cancer centers.
• Demonstrate expertise in oncology, hematology, pathology, molecular diagnostics, and the oncology patient journey while excelling in a fast-paced environment.

• 5+ years of experience in Hematology/Oncology, Surgical, or Diagnostics Sales with a proven track record of success.
• Strong knowledge of academic and community oncology markets, molecular diagnostics, personalized medicine, and reimbursement.
• Ability to travel 50% - 75% within territory.
• Valid driver’s license and safe driving record.
• Excellent communication, presentation, and leadership skills.
• Strategic and forward-thinking with strong business acumen.
• Self-starter with experience in business analysis and a deep understanding of oncology and healthcare trends.
• Ability to collaborate cross-functionally while working independently.

The total on-target earnings (OTE) include a competitive base salary and uncapped quarterly commissions. In addition to OTE, the compensation package also offers a car allowance and RSUs.

OTE: $195,000—$225,000 USD

The compensation listed is for 1st year OTE, based on a wide array of factors unique to each candidate, including skill set, years and depth of experience, certifications, and location. OTE represents the total potential income when performance goals are met and is intended as a guideline rather than a guaranteed amount.

Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.

The Natera team consists of statisticians, geneticists, doctors, laboratory scientists, business professionals, software engineers and many other professionals from world-class institutions who care deeply for our work and each other. When you join Natera, you’ll work hard and grow quickly. Working alongside the elite of the industry, you’ll be stretched and challenged, and take pride in being part of a company that is changing the landscape of genetic disease management.

Comp…